ShinGyu Bae,
CEO
Mr. Shingyu Bae is the founder and CEO of MDimune Inc., which is developing innovative therapeutics for incurable disease with BioDrone® drug delivery platform. He served as the Vice President of Business Development of Kainos Medicine Inc. Prior to joining Kainos Medicine, he was a co-founder and CFO of Chemizon Inc. from 2006 to 2011, when he managed a successful M&A for going public in 2007. He also had experiences of equity investment, M&A and IPO in venture capital for 7 years. Prior to joining venture capital, he worked as a senior research scientist at Daesang R&D Center from 1989-1997. He received M.S. in biotechnology from KAIST in 1988 and B.S. from Ajou University.
|
|
|
